拷贝数剂量调节神经母细胞瘤中端粒维护和与疾病相关的途径
Martin Burkert1,2, Eric Blanc3, Nina Thiessen3
1Department of Biology, Humboldt University, Berlin, Germany.
iScience
|December 5, 2024
概括
神经母细胞瘤中基因拷贝数的变化可以驱动端粒维护和基因组不稳定性,可能提供新的治疗点. 基因组变异的升级表明了对端粒延长的替代途径.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 端粒维持在神经母细胞瘤中至关重要,端粒酶逆转录酶 (TERT) 激活或替代端粒延长 (ALT) 与糟糕的结果有关.
- 虽然TERT激活已被理解,但ALT机制,特别是那些不涉及ATRX变化的机制,仍然不太清楚.
研究的目的:
- 探索超出已知的机制的神经母细胞瘤端粒维护的新途径.
- 为了研究异位基因特异性基因剂量效应在神经母细胞瘤的基因组和端粒调节中的作用.
主要方法:
- 从115个主要神经母细胞瘤样本中分析整个基因组和转录组.
- 关于对端粒维护,基因组稳定性和神经元通路的拷贝数剂量影响的研究.
- 检查TERT激活,基因剂量和基因突变之间的相互作用.
主要成果:
- 发现拷贝数剂量改变可以放松端粒维护,基因组稳定性和神经元通路的调节.
- 鉴定出 histone H3 和 H2A 变体的升调是 ALT. 的潜在替代途径.
- 失去RTL1基因的印记与不良的临床结果有关.
结论:
- 基因剂量在神经母细胞瘤的关键瘤机制中起着重要作用.
- 识别新的端粒维护途径,比如组织素变异升调,提供了潜在的治疗途径.
更多相关视频
08:34Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
10.3K
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.1K
相关概念视频
Replicative Cell Senescence
3.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.6K
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
